ProQR Therapeutics N.V. Quarterly Liabilities in EUR from Q4 2016 to Q4 2023

Taxonomy & unit
ifrs-full: EUR
Summary
ProQR Therapeutics N.V. quarterly Liabilities history and growth rate from Q4 2016 to Q4 2023.
  • ProQR Therapeutics N.V. Liabilities for the quarter ending December 31, 2023 was €96.5M, a 7.79% decline year-over-year.
Liabilities, Quarterly (EUR)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 96.5M -8.15M -7.79% Dec 31, 2023 20-F 2024-03-13
Q3 2023 95.7M +38.5M +67.3% Sep 30, 2023 6-K 2023-11-07
Q2 2023 96.5M +4.41M +4.79% Jun 30, 2023 6-K 2023-08-03
Q1 2023 99.3M +9.3M +10.3% Mar 31, 2023 6-K 2023-05-16
Q4 2022 105M +8.29M +8.6% Dec 31, 2022 20-F 2024-03-13
Q3 2022 57.2M -10.1M -15% Sep 30, 2022 6-K 2022-11-09
Q2 2022 92.1M +47.3M +105% Jun 30, 2022 6-K 2022-08-04
Q1 2022 90M Mar 31, 2022 6-K 2022-05-05
Q4 2021 96.4M +54.2M +128% Dec 31, 2021 20-F 2023-03-29
Q3 2021 67.3M +25.2M +59.9% Sep 30, 2021 6-K 2021-11-04
Q2 2021 44.8M +30.9M +222% Jun 30, 2021 6-K 2021-08-05
Q4 2020 42.2M +18.5M +78% Dec 31, 2020 20-F 2022-04-29
Q3 2020 42.1M +20.5M +94.5% Sep 30, 2020 6-K 2020-11-16
Q2 2020 13.9M -6.09M -30.4% Jun 30, 2020 6-K 2020-08-06
Q1 2020 22.3M Mar 31, 2020 6-K 2020-05-07
Q4 2019 23.7M +6.16M +35.1% Dec 31, 2019 20-F 2021-03-24
Q3 2019 21.6M Sep 30, 2019 6-K 2019-11-12
Q2 2019 20M +5.21M +35.2% Jun 30, 2019 6-K 2019-08-07
Q4 2018 17.5M +3.77M +27.3% Dec 31, 2018 20-F 2020-03-31
Q2 2018 14.8M Jun 30, 2018 6-K 2018-08-08
Q4 2017 13.8M +1.37M +11.1% Dec 31, 2017 20-F 2019-03-28
Q4 2016 12.4M Dec 31, 2016 20-F 2018-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.